8/8/2019 Gw Attachment e
1/2
Scientific Therapeutics Information, IncFebruary 4, 1997Charles
B- Nemeroff, MD, PhDProfessor and ChairmanDept of Psychiatry and
Behavioral SciencesEmory University School of MedicinePO Drawer
AFAtlanta, GA 30322-4990RE: PRIMARY CARS HANDBOOK OF
PSYCHOPHARMACOLOGY
I am pleased to provide an update on the status of this project-
Wehave begun development of the text, and Diane Coniglio, PharmD is
theprimary technical writer and project manager. I will be working
closelywith Diane at all times and will serve as technical editor.
You andAlan are in good hands with Diane; she has many years of
experience andis a creative and accomplished technical writer.We
have developed a timeline for completion of work as follows: Sample
text for preliminary comment Draft I to co-authors/APPI/sponsor
Comments to STI Draft II to co-authors/sponsor Comments to STI
Draft III to co-authors/sponsor forsign-off Production begins Page
proofs to co-authors/APPI/sponsor for final approval Disk to
publisher for printing
Feb 21May 2May 30June 20July 11July 25August 1August 15September
1
A complete content outline is enclosed for your comment. We have
madeseveral key content assumptions as listed below. Please comment
onthese issues.1. Investigational drugs will not be discussed2.
Only oral formulations will be discussed3. Somatization disorder
and general treatment guidelines for elderlyand pregnant/lactating
patients have been added- OK?4. The benzodiazepine-,
antipsychotic-, and barbiturate-classes contain
many drugs. Should we select representative agents from each
ofthese classes rather than discussing the entire class?5. Should
thyroid hormone augmentation of resistant depression be
included or is this an issue not commonly encountered in
primarycare?
WB 193608
505 Motris Avenue. Springfield NJ 07081 *Telephone: (201)
376-5655 Fax: (201) 376-0611 or (201) 376-5567
PAR000011PAR000011
8/8/2019 Gw Attachment e
2/2
Charles B. Nemeroff, MD, PhDFebruary 4, 1997Page 2
I hope that our progress to date meets with your approval.
DianeConiglio will be in touch with you in the near future to
discuss theissues addressed in this letter and to gain the benefit
of your input-In the meantime, please do not hesitate to call me if
you have questionsor require additional information.Sine 1y,
Sally Laden, MSAssociate Editorial Directorenclcc: C
Reinburg
B BrandJ ArmsonJ RomankiewiczM PhilipsD ConiglioJ Leib.1112
WB 193609
PAR000011PAR000011
